Call Us + 33 1 84 88 31 00

Article R5121-103 of the French Public Health Code

When registration is suspended or withdrawn, the holder informs the stockholders without delay. They must take all necessary steps to stop the distribution of the medicinal product. If these steps are not taken within a timeframe compatible with the interests of public health, the Director General of the Agency will take all appropriate measures. Independently of suspension or withdrawal decisions and for the reasons that justify them, the Director General…

Read More »

Article R5121-106 of the French Public Health Code

The application file for registration of a medicinal product or a series of medicinal products mentioned in article L. 5121-13 is sent to the Agency. It includes the following information and documents 1° The name and address of the applicant and the operator of the medicinal product and, where the latter does not manufacture the medicinal product, the name and address of the manufacturer and, where applicable, the name and…

Read More »

Article R5121-107-2 of the French Public Health Code

I.-The registration of the medicinal products mentioned in article L. 5121-13 may be refused, amended, suspended or withdrawn by the Director General of the Agency. The period of suspension may not exceed one year. Decisions to refuse, amend, suspend or cancel registration shall state the reasons on which they are based. They are notified to the applicant or registration holder and state the appeal procedures and deadlines applicable. Such decisions…

Read More »

Article R5121-107-3 of the French Public Health Code

I.-The period of traditional medical use provided for in 4° of Article L. 5121-14-1 is thirty years, including at least fifteen years in a Member State of the European Community or in another State party to the European Economic Area, as attested by bibliographical evidence or expert reports; thirty-year medical use is established even if the product has not been marketed with a specific authorisation or if the number of…

Read More »

Article R5121-107-4 of the French Public Health Code

The registration application file includes the following information and documents, presented in accordance with the order referred to in Article R. 5121-11 : 1° The name and address of the applicant and, where applicable, those of the company exploiting the medicinal product as well as those of the manufacturer when neither the applicant nor the company exploiting the medicinal product manufactures the medicinal product; 2° The name of the medicinal…

Read More »

Article R5121-107-6 of the French Public Health Code

Where the application for registration concerns a herbal substance, a herbal preparation or a combination thereof included in the list drawn up for use in traditional herbal medicinal products by the Commission of the European Communities pursuant to Article 16f of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, the applicant is exempt…

Read More »

Article R5121-107-7 of the French Public Health Code

Where the application for registration concerns a product which has been the subject of a Community herbal monograph established by the Committee for Herbal Medicinal Products of the European Medicines Agency, the Director General of the Agency shall take the monograph into account when examining the application. Where no Community monograph has been established for the product concerned, he may refer to other appropriate monographs, publications or data.

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.